Evidence map›Paper›PMID 36344848›Full record

ArticleNature structural & molecular biology2022

A structural biology community assessment of AlphaFold2 applications.

Mehmet Akdel, Douglas E V Pires, Eduard Porta Pardo, Jürgen Jänes, Arthur O Zalevsky, Bálint Mészáros, Patrick Bryant, Lydia L Good, Roman A Laskowski, Gabriele Pozzati and 24 more

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 366 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
366citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

366 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. AF-CALVADOS: AlphaFold-guided simulations of multi-domain proteins at the proteome level.Protein science : a publication of the Protein Society · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

306 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Mehmet Akdel *Bioinformatics Group, Department of Plant Sciences, Wageningen University and Research, Wageningen, the Netherlands.
Douglas E V Pires *School of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia.
Eduard Porta Pardo *Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
Jürgen Jänes *European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.ORCID http://orcid.org/0000-0002-2540-1236
Arthur O Zalevsky *Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation.ORCID http://orcid.org/0000-0001-6987-8119
Bálint Mészáros *European Molecular Biology Laboratory, Heidelberg, Germany.
Patrick Bryant *Dep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.ORCID http://orcid.org/0000-0003-3439-1866
Lydia L Good *Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5308-8542
Roman A Laskowski *European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.ORCID http://orcid.org/0000-0001-5528-0087
Gabriele PozzatiDep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.ORCID http://orcid.org/0000-0002-4303-9939
Aditi ShenoyDep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.ORCID http://orcid.org/0000-0001-7748-2501
Wensi ZhuDep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.
Petras KundrotasDep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.
Victoria Ruiz SerraBarcelona Supercomputing Center (BSC), Barcelona, Spain.ORCID http://orcid.org/0000-0003-3991-0514
Carlos H M RodriguesSchool of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-4420-6401
Alistair S DunhamEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.ORCID http://orcid.org/0000-0001-9076-3025
David BurkeEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.ORCID http://orcid.org/0000-0001-8830-3951
Neera BorkakotiEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Sameer VelankarEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.ORCID http://orcid.org/0000-0002-8439-5964
Adam FrostDepartment of Biochemistry and Biophysics University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-2231-2577
Jérôme BasquinDepartment of Structural Cell Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.
Kresten Lindorff-LarsenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-4750-6039
Alex BatemanEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.ORCID http://orcid.org/0000-0002-6982-4660
Andrey V KajavaUniversité de Montpellier, Centre de Recherche en Biologie Cellulaire de Montpellier (CRBM) CNRS, Montpellier, France.ORCID http://orcid.org/0000-0002-2342-6886
Alfonso ValenciaBarcelona Supercomputing Center (BSC), Barcelona, Spain. alfonso.valencia@bsc.es.ORCID http://orcid.org/0000-0002-8937-6789
Sergey OvchinnikovFaculty of Arts and Sciences, Division of Science, Harvard University, Cambridge, MA, USA. so@fas.harvard.edu.ORCID http://orcid.org/0000-0003-2774-2744
Janani DurairajBiozentrum, University of Basel, Basel, Switzerland. janani.durairaj@gmail.com.ORCID http://orcid.org/0000-0002-1698-4556
David B AscherSchool of Chemistry and Molecular Biology, University of Queensland, Brisbane, Queensland, Australia. d.ascher@uq.edu.au.ORCID http://orcid.org/0000-0003-2948-2413
Janet M ThorntonEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK. thornton@ebi.ac.uk.ORCID http://orcid.org/0000-0003-0824-4096
Norman E DaveyInstitute of Cancer Research, London, UK. norman.davey@icr.ac.uk.ORCID http://orcid.org/0000-0001-6988-4850
Amelie SteinLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark. amelie.stein@bio.ku.dk.ORCID http://orcid.org/0000-0002-5862-1681
Arne ElofssonDep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden. arne@bioinfo.se.ORCID http://orcid.org/0000-0002-7115-9751
Tristan I CrollCambridge Institute for Medical Research, Department of Haematology, The University of Cambridge, Cambridge, UK. tic20@cam.ac.uk.ORCID http://orcid.org/0000-0002-3514-8377
Pedro BeltraoEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK. pbeltrao@ethz.ch.ORCID http://orcid.org/0000-0002-2724-7703

Funding

Exploring the unknown protein universe using evolutionary informationDP5OD026389 · OD · HARVARD UNIVERSITY · PI OVCHINNIKOV, SERGEY L. · 2018 to 2022
$2.0M
Structural analysis of inner membrane platform in the type 2 secretion systemR21AI156595 · NIAID · YALE UNIVERSITY · PI MI, WEI · 2021 to 2022
$492k
Cancer Research UK 28159NIAID NIH HHS R21 AI156595NIH HHS DP5 OD026389Wellcome Trust
6 · The paper itself

Abstract

Most proteins fold into 3D structures that determine how they function and orchestrate the biological processes of the cell. Recent developments in computational methods for protein structure predictions have reached the accuracy of experimentally determined models. Although this has been independently verified, the implementation of these methods across structural-biology applications remains to be tested. Here, we evaluate the use of AlphaFold2 (AF2) predictions in the study of characteristic structural elements; the impact of missense variants; function and ligand binding site predictions; modeling of interactions; and modeling of experimental structural data. For 11 proteomes, an average of 25% additional residues can be confidently modeled when compared with homology modeling, identifying structural features rarely seen in the Protein Data Bank. AF2-based predictions of protein disorder and complexes surpass dedicated tools, and AF2 models can be used across diverse applications equally well compared with experimentally determined structures, when the confidence metrics are critically considered. In summary, we find that these advances are likely to have a transformative impact in structural biology and broader life-science research.

Indexed as

Computational BiologyFurylfuramideBinding SitesDatabases, ProteinProtein ConformationProteinsFurylfuramideProteins

Identifiers

PMID36344848
PMCPMC9663297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.